Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity.
Cell
; 165(7): 1621-1631, 2016 Jun 16.
Article
in En
| MEDLINE
| ID: mdl-27315479
Full text:
1
Database:
MEDLINE
Main subject:
HIV-1
/
Antibodies, Bispecific
/
HIV Envelope Protein gp160
/
Antibodies, Neutralizing
Limits:
Animals
/
Humans
Language:
En
Journal:
Cell
Year:
2016
Type:
Article
Affiliation country:
United States